HELLS and retinoblastoma: Zocchi et al. (2020) found that low expression of HELLS in retinoblastoma inhibited ectopic division of differentiated cells in the retina, leading to tumor development inhibition and, consequently, prolonging OS in patients (Zocchi et al., 2020; Xing et al., 2021).